Treating DNA Repair-deficient Breast Cancers
Several clinical trials are underway in which PARP inhibitors are being tested in breast cancers, mostly triple-negative breast cancers,...
Category: AACR
Several clinical trials are underway in which PARP inhibitors are being tested in breast cancers, mostly triple-negative breast cancers,...
Paul Northcott, PhD, inaugural recipient of the AACR NextGen Grant for Transformative Cancer Research, has dedicated his research career...
Beginning this Friday, Philadelphia will host the 2017 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. The conference,...
Despite advances in treatment, nearly 1,800 children and adolescents in the U.S. die annually from cancer. In an article...
For the second consecutive year, the American Association for Cancer Research (AACR) has been designated the beneficiary of Party...
In recent years, the U.S. Food and Drug Administration has approved immune checkpoint inhibitors, a class of immunotherapy, to...
Mubarak Labaran Liman has overcome the death of his father and a scarcity of resources to develop a thriving...
Scientific advancements are made through scientific research. From understanding the basic biology behind a disease to testing how well...
On Sunday, almost 300 of the greatest minds in ovarian cancer research will come together in Pittsburgh to discuss...
The U.S. Latino population surged 243 percent from 1980 to 2010. But in the same time span, the Latino...